A new product of the "Alzheimer's Clock" can be slowed down to appear at the fair

5-10, the 3rd China International Import Expo (hereinafter referred to as the Expo) was held in Shanghai. At the expo, Danon Newdichia announced the progress of a study on Alzheimer's disease. In a three-year clinical study of early-stage Alzheimer's patients, the team found that by "medically raising the brain", the clock could be set to slow down the progression of Alzheimer's disease.
In the three-year study, researchers used a special nutritional intervention called Souvenaid Wisdom Agile to target early-stage Alzheimer's patients, which showed that the measure slowed the decline in clinical indicators associated with cognitive function, brain atrophy and disease development, and the longer they received the intervention, the more effective it beed, according to researchers at Danon Newdishia. The findings were published November 5 in the journal Alzheimer's disease and dementia.
results provide doctors with a special, evidence-based, medically validated nutritional program that can be recommended to patients with mild cognitive impairment (early Alzheimer's disease). Patrick Kamphuis, director of global medical affairs at Danon Newdishia, one of the researchers, told China Science.
, a special nutritional intervention product used by the Institute, was also unveiled at the expo. According to the introduction, wisdom agile contains a variety of specific nutrients, including the formation of synaptic membranes required for the key nutrients and a variety of difficult to get enough nutrients from the daily diet of the brain. Studies have confirmed that moderate Alzheimer's patients who consume quantitative mental agility daily can improve cognition and delay brain decline for three consecutive months, slowing down the "Alzheimer's clock".
, the prevalence of Alzheimer's disease among people over 60 in China is as high as 6.19 per cent. "Healthy China 2030 Planning Outline" specifically proposed to "strengthen the effective intervention of Alzheimer's disease." Since 2003, Danon Newdichia has worked with the Massachusetts Institute of Technology (MIT) Neurocognitive Laboratory to develop medical nutritional formulations for the treatment of neurological diseases, and over the next 20 years has collaborated with a number of research centers around the world on a range of clinical studies. (Source: Zhao Guangli, China Science Journal)
paper Information: